Drug-Induced Graves Disease From CTLA-4 Receptor Suppression

Ophthalmic Plastic and Reconstructive Surgery

Volumn 27, Issue 4, 2011, Pages e87-e88

  Borodic, Gary ^a   Hinkle, David M ^a   Cia, Yihong ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IPILIMUMAB; LIOTHYRONINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CASE REPORT; CD8+ T LYMPHOCYTE; DIPLOPIA; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; FEMALE; HUMAN; KERATITIS; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PHYSICAL DISEASE BY BODY FUNCTION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR CELL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; DIPLOPIA; EXOPHTHALMOS; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MELANOMA; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; OCULOMOTOR MUSCLES;

EID: 79960559927     PISSN: 07409303     EISSN: 15372677     Source Type: Journal    
DOI: 10.1097/IOP.0b013e3181ef72a1     Document Type: Article

References (5)

1. Smith-Garvin JE, Koretzky GA, Jordan MS. T cell activation. Annu Rev Immunol 2009;27:591-619.
2. Yanagawa T, Hidaka Y, Guimaraes V, et al. CTLA-4 gene polymorphism associated with Graves’ disease in a Caucasian population. J Clin Endocrinol Metab 1995;80:41-5.
3. Dittmar M, Kahaly GJ. Immunoregulatory and susceptibility genes in thyroid and polyglandular autoimmunity. Thyroid 2005;15:239-50.
4. Naik V, Khadavi N, Naik MN, et al. Biologic therapeutics in thyroid-associated ophthalmopathy: translating disease mechanism into therapy. Thyroid 2008;18:967-71.
5. Bashey A, Medina B, Corringham S, et al. CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation. Blood 2009;113:1581-8.